Sustained-Release Griffithsin Nanoparticle-Fiber Composites against HIV-1 and HSV-2 Infections

Human immunodeficiency virus (HIV-1) and herpes simplex virus 2 (HSV-2) affect hundreds of millions of people worldwide. The antiviral lectin, Griffithsin (GRFT), has been shown to be both safe and efficacious against HSV-2 and HIV-1 infections in vivo. The goal of this work was to develop a multila...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Control Release
Autores principales: Tyo, Kevin M., Lasnik, Amanda B., Zhang, Longyun, Mahmoud, Mohamed, Jenson, Alfred B., Fuqua, Joshua L., Palmer, Kenneth E., Steinbach-Rankins, Jill M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170769/
https://ncbi.nlm.nih.gov/pubmed/32035194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.02.006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares